The Potential of Carbon Monoxide (CO) as a Therapeutic Agent in Cancer Treatment: A Literature Review
Potensi Karbon Monoksida Sebagai Agen Terapeutik Dalam Pengobatan Kanker: Tinjauan Literatur
DOI:
https://doi.org/10.70392/jrn.v2i2.5664Keywords:
Anti-cancer therapy, Cancer, Carbon monoxideAbstract
Background: Carbon monoxide (CO) has shown potential as an anti-cancer therapy, rather than simply functioning as a toxin. Recent research indicates that carbon monoxide (CO), which is a carbon-based nanoparticle, can target cancer cells and induce apoptosis. CO shows promising cytotoxic activity against cancer cell lines as one of the therapies in cancer treatment. The purpose of this article is to present a concise look at the physiological and biochemical traits of CO and the mechanism of its therapeutic potential in the treatment of cancer Methods: This study is a literature review. The database used in the search for this article using google scholar, pubmed, and elsevier. the data collection process uses the keywords “Carbon Monoxide, cancer, anti- cancer therapy” which are taken from the results of research that has been done previously both from within and outside the country. The results of this research article review are Carbon Monoxide (CO) not only has a toxic effect but also has a cytotoxic effect on cancer cells. In cancer cells treated with CO, there was a significant reduction in Akt (protein kinase B) phosphorylation, a key factor in cancer neovascularization, by 30-50%.
References
Bi, J., Witt, E., Mcgovern, M.K., Cafi, A.B., Rosenstock, L.L., Pearson, A.B., Brown, T.J., Karasic, T.B., Absler, L.C., Machkanti, S., Boyce, H., Gallo, D., Becker, S.L., Ishida, K., Jenkins, J., Hayward, A., Scheiflinger, A., Bodeker, K.L., Kumar, R., Shaw, S.K., Byrne, J.D. Oral carbon monoxide enhances autophagy modulation in prostate, pancreatic, and lung cancers. Advanced Science 2024, 11(9), E2308346.
Krukowska, K., Magierowski, M. Carbon monoxide (CO)/heme oxygenase (HO)-1 in gastrointestinal tumors pathophysi-ology and pharmacology—possible anti- and pro-cancer activities. Biochemical Pharmacology 2022, 201, 115058.
Kawahara, B., Sen, S., Mascharak, P.K. Reaction of carbon monoxide with cystathionine Β synthase: Implications on drug efficacies in cancer chemotherapy. Future Medicinal Chemistry 2020, 12(4), 325– 337.
Wang, B., Yi, C.N.D. The anti-metastasis effect of low-dose carbon mono. Annals of Pancreatic Cancer 2023, 6(01), 1-5.
Vo, T.T.T ., Canh, V.Q., Tuan, V.P., Wee, Y., Lee, S.T. The potential of carbon monoxide-releasing molecular in cancer treatment: An outlook from ROS biologi and medicine. Redox Biologi 202, 46, 1-12
Bilska-Wilkosz, A., Górny, M., Iciek, M. Sifat biologis dan farmakologis karbon monoksida: Tinjauan umum. Oksigen 2022, 2(2), 130-151.
Puett, R.C., Poulsen, A.H., Taj, T., Ketzel, M., Geels, C., Brandt, J., Christensen, J.H., Sorensen, M., Roswall, N., Hvidrfeldt, U., Raaschou-Nielsen, O. Relationship of leukaemias with long-term ambient air pollution exposures in the adult Danish population. British Journal of Cancer 2020, 123(12), 1818-1824.
Fang, J., Islam, R., Islam, W., Yin, H., Subr, V., Etrych, T., Maeda, H. Augmentation of EPR effect and efficacy of anti-cancer nanomedicine by carbon monoxide generating agents. Pharmaceutics 2019, 11(7), 343.
Fang, Y., Yang, J., Liang, X., Wu, J., Xie, M., Zhang, K., Su, C. Endogenous and exogeneous stimulitriggered reactive oxygen species evoke long-lived carbon monoxide to fight against lung cancer. Journal of Nanobiotechnology 2024, 22(1), 416.
Wahid, R.S.A., Rahman, M.P.S., Raudah, S., Utami, R.A., Mawardani, M.T. Analisa kadar karboksihemoglobin (COHB) pada darah pedagang kaki lima di pasar tradisional Kota Samarinda. Borneo Journal of Medical Laboratory Technology 2024, 7(1), 598-605.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Erwin Samsul, Jingga Apriani Jevita Dewi, Inayah Yuli Agustina, Meilda Keysia Angelica Atmadja, Irene Aliet Rombe, Cindy Nabilah, Mila Kansia Sari, Nur Arinda Putri (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
						 
							












